{"id":"W2023231007","doi":"10.1016/j.jcjd.2013.08.126","title":"Efficacy and Safety of Dulaglutide Versus Placebo and Exenatide in Type 2 Diabetes (AWARD-1)","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Exenatide; Dulaglutide; Placebo; Type 2 diabetes; Incidence (geometry); Metformin; Internal medicine; Gastroenterology; Randomized controlled trial; Adverse effect; Diabetes mellitus; Endocrinology; Insulin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001666872,0.0007401374,0.002937212,0.0003452292,0.00037724,0.0008637481,0.0006936441,0.0009369151,0.003038606],"category_scores_gemma":[0.0019512,0.0003410983,0.001561951,0.0002874136,0.000610165,0.001175348,0.000477351,0.001800325,0.0003779114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005727758,"about_ca_system_score_gemma":0.0007192087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008753801,"about_ca_topic_score_gemma":0.00168073,"domain_scores_codex":[0.9993504,0.0002785164,0.00006925241,0.00009619578,0.00006584948,0.0001397712],"domain_scores_gemma":[0.9989696,0.0002504587,0.0001999375,0.00008409438,0.00005652554,0.0004394281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9531957,0.00729731,0.003673719,0.0002539863,0.0005431323,0.00004150548,0.00004538506,0.0001764531,0.00260983,0.00004643192,0.0002288059,0.03188773],"study_design_scores_gemma":[0.4978441,0.4314563,0.06215958,0.0001384968,0.001855566,0.000212868,0.000241938,0.001049069,0.003479165,0.000277567,0.001202798,0.00008261541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959298,0.002593177,0.00008363565,0.0001466483,0.0001257523,0.0001167413,0.0002761782,0.00002146577,0.0007066405],"genre_scores_gemma":[0.9969653,0.001162847,0.0002383671,0.0001692823,0.0001500927,0.0001163443,0.0003911474,0.000006837292,0.0007997421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003038606,"threshold_uncertainty_score":0.01016515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01114081771908757,"score_gpt":0.2225710513030658,"score_spread":0.2114302335839782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}